MedTrace Logo

The Effect of Oxytocin on Face Perception

NCT02091817 · Status: SUSPENDED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether oxytocin affect face perception

Conditions

  • Healthy
  • Congenital Prosopagnosia

Interventions

DRUG

Oxytocin

Intervention will be examined on control group, and on experimental group as well.

DRUG

Placebo

Placebo will be given to control group and experimental group as well.

Sponsors & Collaborators

  • Ben-Gurion University of the Negev

    collaborator OTHER

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • Shelef Ilan, MD · Soroka University Medical Center

  • Galia Avidan, Ph.D · Ben-Gurion University of the Negev

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2016-12-31
Completion
2017-12-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02091817 on ClinicalTrials.gov